Annual CFO:
$184.15M+$254.39M(+362.19%)Summary
- As of today, PTGX annual cash from operations is $184.15 million, with the most recent change of +$254.39 million (+362.19%) on December 31, 2024.
- During the last 3 years, PTGX annual cash from operations has risen by +$292.02 million (+270.72%).
- PTGX annual cash from operations is now at all-time high.
Performance
PTGX Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFO:
-$28.78M-$154.14M(-122.96%)Summary
- As of today, PTGX quarterly cash from operations is -$28.78 million, with the most recent change of -$154.14 million (-122.96%) on June 30, 2025.
- Over the past year, PTGX quarterly cash from operations has dropped by -$297.40 million (-110.71%).
- PTGX quarterly cash from operations is now -110.71% below its all-time high of $268.62 million, reached on June 30, 2024.
Performance
PTGX Quarterly Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
$39.54M-$297.40M(-88.26%)Summary
- As of today, PTGX TTM cash from operations is $39.54 million, with the most recent change of -$297.40 million (-88.26%) on June 30, 2025.
- Over the past year, PTGX TTM cash from operations has dropped by -$192.00 million (-82.92%).
- PTGX TTM cash from operations is now -88.26% below its all-time high of $336.94 million, reached on March 31, 2025.
Performance
PTGX TTM Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
PTGX Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +362.2% | -110.7% | -82.9% |
| 3Y3 Years | +270.7% | -111.1% | +137.1% |
| 5Y5 Years | +543.5% | -34.0% | +158.2% |
PTGX Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +270.3% | -110.7% | +16.2% | -88.3% | +133.3% |
| 5Y | 5-Year | at high | +270.3% | -110.7% | +23.6% | -88.3% | +133.3% |
| All-Time | All-Time | at high | +270.3% | -110.7% | +23.6% | -88.3% | +133.3% |
PTGX Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$28.78M(-123.0%) | $39.54M(-88.3%) |
| Mar 2025 | - | $125.36M(+529.6%) | $336.94M(+83.0%) |
| Dec 2024 | $184.15M(+362.2%) | -$29.18M(-4.7%) | $184.15M(-20.0%) |
| Sep 2024 | - | -$27.86M(-110.4%) | $230.29M(-0.5%) |
| Jun 2024 | - | $268.62M(+1079.3%) | $231.54M(+465.7%) |
| Mar 2024 | - | -$27.43M(-261.7%) | -$63.32M(+9.8%) |
| Dec 2023 | -$70.24M(+35.0%) | $16.96M(+163.7%) | -$70.24M(+40.9%) |
| Sep 2023 | - | -$26.61M(-1.4%) | -$118.83M(-1.2%) |
| Jun 2023 | - | -$26.24M(+23.6%) | -$117.42M(-12.0%) |
| Mar 2023 | - | -$34.35M(-8.6%) | -$104.82M(+3.1%) |
| Dec 2022 | -$108.14M(-0.3%) | -$31.64M(-25.5%) | -$108.14M(-4.5%) |
| Sep 2022 | - | -$25.20M(-84.8%) | -$103.44M(+3.1%) |
| Jun 2022 | - | -$13.63M(+63.8%) | -$106.71M(+8.6%) |
| Mar 2022 | - | -$37.67M(-39.8%) | -$116.78M(-8.3%) |
| Dec 2021 | -$107.86M(-48.8%) | -$26.94M(+5.4%) | -$107.86M(-8.1%) |
| Sep 2021 | - | -$28.47M(-20.1%) | -$99.79M(-13.9%) |
| Jun 2021 | - | -$23.70M(+17.6%) | -$87.61M(-2.6%) |
| Mar 2021 | - | -$28.76M(-52.4%) | -$85.39M(-17.8%) |
| Dec 2020 | -$72.48M | -$18.87M(-15.8%) | -$72.48M(-6.7%) |
| Sep 2020 | - | -$16.29M(+24.2%) | -$67.91M(-3.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2020 | - | -$21.48M(-35.6%) | -$65.86M(-61.8%) |
| Mar 2020 | - | -$15.85M(-10.9%) | -$40.71M(+2.0%) |
| Dec 2019 | -$41.53M(+16.9%) | -$14.29M(-0.3%) | -$41.53M(-11.1%) |
| Sep 2019 | - | -$14.25M(-488.2%) | -$37.37M(-15.3%) |
| Jun 2019 | - | $3.67M(+122.0%) | -$32.40M(+37.0%) |
| Mar 2019 | - | -$16.66M(-64.4%) | -$51.47M(-3.1%) |
| Dec 2018 | -$49.95M(-1390.0%) | -$10.13M(-9.3%) | -$49.95M(+7.4%) |
| Sep 2018 | - | -$9.28M(+39.8%) | -$53.96M(-1255.5%) |
| Jun 2018 | - | -$15.40M(-1.7%) | -$3.98M(-337.5%) |
| Mar 2018 | - | -$15.14M(-7.0%) | -$910.00K(-123.5%) |
| Dec 2017 | $3.87M(+112.9%) | -$14.15M(-134.8%) | $3.87M(-53.6%) |
| Sep 2017 | - | $40.70M(+430.2%) | $8.34M(+121.2%) |
| Jun 2017 | - | -$12.33M(-19.0%) | -$39.34M(-12.1%) |
| Mar 2017 | - | -$10.36M(-7.0%) | -$35.09M(-17.1%) |
| Dec 2016 | -$29.97M(-108.4%) | -$9.68M(-38.7%) | -$29.97M(-19.7%) |
| Sep 2016 | - | -$6.98M(+13.5%) | -$25.03M(-38.7%) |
| Jun 2016 | - | -$8.07M(-54.1%) | -$18.05M(-80.9%) |
| Mar 2016 | - | -$5.24M(-10.6%) | -$9.98M(-39.1%) |
| Dec 2015 | -$14.38M(-85.8%) | -$4.74M(-94.8%) | -$7.17M(-194.8%) |
| Mar 2015 | - | -$2.43M | -$2.43M |
| Dec 2014 | -$7.74M | - | - |
FAQ
- What is Protagonist Therapeutics, Inc. annual cash from operations?
- What is the all-time high annual cash from operations for Protagonist Therapeutics, Inc.?
- What is Protagonist Therapeutics, Inc. annual cash from operations year-on-year change?
- What is Protagonist Therapeutics, Inc. quarterly cash from operations?
- What is the all-time high quarterly cash from operations for Protagonist Therapeutics, Inc.?
- What is Protagonist Therapeutics, Inc. quarterly cash from operations year-on-year change?
- What is Protagonist Therapeutics, Inc. TTM cash from operations?
- What is the all-time high TTM cash from operations for Protagonist Therapeutics, Inc.?
- What is Protagonist Therapeutics, Inc. TTM cash from operations year-on-year change?
What is Protagonist Therapeutics, Inc. annual cash from operations?
The current annual cash from operations of PTGX is $184.15M
What is the all-time high annual cash from operations for Protagonist Therapeutics, Inc.?
Protagonist Therapeutics, Inc. all-time high annual cash from operations is $184.15M
What is Protagonist Therapeutics, Inc. annual cash from operations year-on-year change?
Over the past year, PTGX annual cash from operations has changed by +$254.39M (+362.19%)
What is Protagonist Therapeutics, Inc. quarterly cash from operations?
The current quarterly cash from operations of PTGX is -$28.78M
What is the all-time high quarterly cash from operations for Protagonist Therapeutics, Inc.?
Protagonist Therapeutics, Inc. all-time high quarterly cash from operations is $268.62M
What is Protagonist Therapeutics, Inc. quarterly cash from operations year-on-year change?
Over the past year, PTGX quarterly cash from operations has changed by -$297.40M (-110.71%)
What is Protagonist Therapeutics, Inc. TTM cash from operations?
The current TTM cash from operations of PTGX is $39.54M
What is the all-time high TTM cash from operations for Protagonist Therapeutics, Inc.?
Protagonist Therapeutics, Inc. all-time high TTM cash from operations is $336.94M
What is Protagonist Therapeutics, Inc. TTM cash from operations year-on-year change?
Over the past year, PTGX TTM cash from operations has changed by -$192.00M (-82.92%)